Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
Number of biotech orphan drugs marketed in Italy between 2016 and 2017, by type (in units)
This statistic depicts the number of biotech orphan drugs available on the Italian pharmaceutical market between 2016 and 2017, by type. According to data, most of the biotech products available aimed at treating rare diseases were based on proteins obtained through recombinant DNA (15 treatments). Pertaining to gene therapy and tissue engineering only one treatment each was available in Italy up to 2017.
Number of biotech orphan drugs marketed in Italy between 2016 and 2017, by type (in units)
Source
More information
Statistics on "Pharmaceutical trends in Europe"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Italy: number of biotech drugs marketed 2016-2017, by type
- Top new orphan molecular entities by U.S. sales in 2019
- Italy: turnover of biotech drugs 2014-2017
- Italy: value of investments in R&D of biotech pharma companies 2014-2017
- Italy: number of R&D employees of biotech pharma companies 2014-2017
- Italy: number of biotech companies in the pharma sector 2014-2017
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Worldwide Rx drug sales excluding generics and orphan drugs 2002-2024
- Orphan vs. non-orphan pipeline sales forecast worldwide 2019-2024
- Top drugs based on projected 2019 year-on-year sales increase
- Count of first-time medtech approvals granted by FDA 2006-2017
- Projection of top 10 global pharmaceutical products by revenue 2019
- Utilization of orphan drugs in the U.S. from 2012 to 2014, by usage type
- Cumulative price change of orphan drugs in the U.S. 2012-2014
- Utilization of orphan drugs in the U.S. by usage type 2014
- Mean cost of U.S. opioid marketing 2013-2015, by ethnicity
- Number of opioid marketing payments in the U.S. in 2013-2015, by ethnicity
Statistics on "Pharmaceutical trends in Europe"
Related topics
About Statista
